摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-1,2,3,4-tetrahydro-5-methoxy-N-propyl-naphthalen-2-ammonium (S)-2-hydroxy-3-phenylpropionate | 1352917-67-9

中文名称
——
中文别名
——
英文名称
(S)-1,2,3,4-tetrahydro-5-methoxy-N-propyl-naphthalen-2-ammonium (S)-2-hydroxy-3-phenylpropionate
英文别名
(2S)-2-hydroxy-3-phenylpropanoate;[(2S)-5-methoxy-1,2,3,4-tetrahydronaphthalen-2-yl]-propylazanium
(S)-1,2,3,4-tetrahydro-5-methoxy-N-propyl-naphthalen-2-ammonium (S)-2-hydroxy-3-phenylpropionate化学式
CAS
1352917-67-9
化学式
C9H10O3*C14H21NO
mdl
——
分子量
385.503
InChiKey
JIRDMGQEXXRHDU-KEUUFYAISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.87
  • 重原子数:
    28
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    86.2
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] A PROCESS FOR THE PREPARATION OF ROTIGOTINE<br/>[FR] PROCÉDÉ DE PRÉPARATION DE LA ROTIGOTINE
    申请人:FIDIA FARMACEUTICI
    公开号:WO2010035111A1
    公开(公告)日:2010-04-01
    A process for the preparation of Rotigotine (I) and of pharmaceutically acceptable salts thereof, which comprises the reductive amination of an amine of formula 6 with the 2-thienylacetic acid- sodium boron hydride complex and which makes use of hydrobromide 5 as an intermediate (II) The process is advantageous from the industrial point of view in that it allows to obtain Rotigotine with high enantiomeric purity starting from optically active 5,6,7,8-tetrahydro-6-(S)-N-propylamino-l-methoxy- naphthalene (2), avoiding the use of dangerous reactives, the need for difficult chromatographic separation or the formation of by-products. Furthermore, two novel crystalline forms are disclosed.
    一种制备罗地高辛(I)及其药学上可接受的盐的方法,其包括使用2-噻吩乙酸钠硼氢化物复合物对式为6的胺进行还原胺化反应,并利用羟溴酸5作为中间体(II)。该方法从工业角度来看具有优势,因为它允许从光学活性的5,6,7,8-四氢-6-(S)-N-丙基氨基-1-甲氧基-萘(2)开始获得高对映纯度的罗地高辛,避免使用危险的反应物,需要困难的色谱分离或产生副产物。此外,还公开了两种新的结晶形式。
  • Process for the preparation of rotigotine
    申请人:Banfi Aldo
    公开号:US08519160B2
    公开(公告)日:2013-08-27
    A process for the preparation of Rotigotine (I) and of pharmaceutically acceptable salts thereof, which comprises the reductive amination of an amine of formula 6 with the 2-thienylacetic acid-sodium boron hydride complex and which makes use of hydrobromide 5 as an intermediate (II). The process is advantageous from the industrial point of view in that it allows to obtain Rotigotine with high enantiomeric purity starting from optically active 5,6,7,8-tetrahydro-6-(S)-N-propylamino-1-methoxynaphthalene (2), avoiding the use of dangerous reactives, the need for difficult chromatographic separation or the formation of by-products. Furthermore, two novel crystalline forms are disclosed.
    一种制备Rotigotine(I)及其药学上可接受的盐的方法,其包括将6式胺与2-噻吩乙酸-硼氢化钠复合物进行还原胺化反应,并利用羟溴酸5作为中间体(II)。该工艺在工业角度上具有优势,因为它允许从光学活性的5,6,7,8-四氢-6-(S)-N-丙基氨基-1-甲氧基萘(2)开始获得高对映纯度的Rotigotine,避免使用危险反应物、需要困难的色谱分离或副产物的形成。此外,还披露了两种新的晶体形式。
  • [EN] NOVEL PROCESS FOR THE PREPARATION OF NITROGEN SUBSTITUTED AMINOTETRALINS DERIVATIVES<br/>[FR] NOUVEAU PROCÉDÉ POUR LA PRÉPARATION DE DÉRIVÉS D'AMINOTÉTRALINES SUBSTITUÉS SUR L'AZOTE
    申请人:UCB PHARMA GMBH
    公开号:WO2011161255A2
    公开(公告)日:2011-12-29
    The present invention provides an alternative synthesis of N-substituted aminotetralines comprising resolution of N-substituted aminotetralins of formula (II), wherein R1, R2 and R3 are as defined for compound of formula (I).
    本发明提供了一种N-取代氨基四氢萘的替代合成方法,包括通过分离式分辨式合成式(II)的N-取代氨基四氢萘,其中R1、R2和R3与式(I)的化合物定义相同。
  • Process for the preparation of nitrogen substituted aminotetralins derivatives
    申请人:Ates Celal
    公开号:US08981121B2
    公开(公告)日:2015-03-17
    The present invention provides an alternative synthesis of N-substituted aminotetralines comprising resolution of N-substituted aminotetralins of formula (II), wherein R1, R2 and R3 are as defined for compound of formula (I).
    本发明提供了N-取代氨基四氢萘的替代合成方法,包括通过分离式解析式(II)中的N-取代氨基四氢萘来实现,其中R1、R2和R3与式(I)的化合物定义相同。
  • PROCESSES FOR THE RESOLUTION OF NITROGEN SUBSTITUTED (S)-5-ALKOXY-2-AMINOTETRALIN DERIVATIVES
    申请人:UCB Biopharma SPRL
    公开号:EP2585428B1
    公开(公告)日:2017-05-10
查看更多